Avastin and Retinal tear - a phase IV clinical study of FDA data

Summary:

Retinal tear is reported as a side effect among people who take Avastin (bevacizumab), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Lucentis, and have Age-related macular degeneration.

The phase IV clinical study analyzes which people have Retinal tear when taking Avastin. It is created by eHealthMe based on reports of 75,729 people who have side effects when taking Avastin from the FDA, and is updated regularly.

What is Avastin?

Avastin has active ingredients of bevacizumab. It is often used in high blood cholesterol. eHealthMe is studying from 76,365 Avastin users. Check the latest studies of Avastin.

What is Retinal tear?

Retinal tear is found to be associated with 326 drugs and 466 conditions by eHealthMe. Check the latest studies of Retinal tear.

On Jul, 20, 2026

75,729 people reported to have side effects when taking Avastin.
Among them, 50 people (0.07%) have Retinal tear.

Among these 50 people:

How long have people been on Avastin when they have Retinal tear? *

What is the gender of people who have Retinal tear when taking Avastin? *

female: 47.73 %
male: 52.27 %

What is the age of people who have Retinal tear when taking Avastin? *

What are other drugs people take besides Avastin? *

What are other side effects people have besides Retinal tear? *

Cataract (clouding of the lens inside the eye): 12 people, 24.00%
Vitreous Haemorrhage (intraocular (inside the eye) bleeding): 9 people, 18.00%
Retinal Haemorrhage (bleeding from retina): 8 people, 16.00%
Visual Acuity Reduced (reduced clearness of vision): 8 people, 16.00%
Vision Blurred: 8 people, 16.00%
Blindness Unilateral: 7 people, 14.00%
Visual Impairment: 7 people, 14.00%
Headache (pain in head): 6 people, 12.00%
Stress And Anxiety: 6 people, 12.00%
Lacrimation Increased: 6 people, 12.00%

What are the existing conditions these people have? *

Age-Related Macular Degeneration: 8 people, 16.00%
Diabetic Retinopathy (damage to the retina caused by complications of diabetes): 5 people, 10.00%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 5 people, 10.00%
Colon Cancer Metastatic (cancer of colon spreads to other part of body): 4 people, 8.00%
Retinal Vessel Occlusion (a blockage in one of the small arteries): 3 people, 6.00%
Breast Cancer Metastatic: 3 people, 6.00%
Choroidal Neovascularisation (creation of new blood vessels in vascular layer of eye): 3 people, 6.00%
Glaucoma (increased fluid pressure in the eye with vision loss): 3 people, 6.00%
Lung Adenocarcinoma (a form of non-small cell lung cancer): 2 people, 4.00%
Eye Oedema (swelling or thickening of the macula, the area of the retina responsible for central vision): 2 people, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take Avastin and have Retinal tear?

- Check whether Retinal tear is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Avastin:

Avastin (76,365 reports)

Retinal tear treatments and more:

Retinal tear (2,985 reports)

Browse all side effects of Avastin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Retinal tear:

Retinal tear (326 drugs)

Browse all the conditions that are associated with Retinal tear:

Retinal tear (466 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on bevacizumab (the active ingredients of Avastin) and Avastin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.